LAFAYETTE, IND. — Eli Lilly and Company has agreed to sell its Tippecanoe Laboratories manufacturing facility to Evonik Industries AG, one of the world’s largest chemical companies. The facility, which is located in Lafayette, will remain in operation with a focus on producing high-quality active pharmaceuticals ingredients (API) and specialty chemical and animal health products. Concurrent with the sale, the two companies will enter into a 9-year supply and services agreement, whereby Evonik will manufacture API for certain Lilly human and animal health products. Additional terms of the transaction were not disclosed.